An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis

Rare Care Podcast
02/07/2025 13 min Temporada 1 Episodio 179
An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis

Listen "An Interview With Dr. Daniel Grant, VP and Global Program Head at Novartis"

Descargar episodio Ver en sitio original

Episode Synopsis

Larry Luxner, senior correspondent for Rare Disease Advisor, interviews Daniel Grant, MD, vice president and global program head of neuroscience and gene therapy at Swiss pharma giant Novartis, on emerging therapies for SMA.

More episodes of the podcast Rare Care Podcast

An Interview With Sickle Cell Disease Patient Advocate Golie-Lorenzo Green 30/12/2025
An Interview With Jana Monaco, a NORD Patient Ambassador From Virginia 22/12/2025
An Interview With Dr. Matthew Might on How AI Could Transform Genome-Guided Medicine 17/12/2025
An Interview With Dr. Sarah Chang on the Patient and Caregiver Burden of TK2d 08/12/2025
An Interview With Rheumatologist Jinoos Yazdany on the Dangers of Artificial Intelligence 03/12/2025
An Interview With Dr. Barry Byrne, Director of the UF Powell Gene Therapy Center 24/11/2025
An Interview With Rheumatologist Eric Matteson, Winner of the ACR's 2025 Presidential Gold Medal 19/11/2025
An Interview With New Mexico Patient Ambassador Karen Smoot of the Pulmonary Fibrosis Foundation 11/11/2025
An Interview With Gabriela Romanow, Founder of Rare Vision, a Project That Helps Artists With Rare Neuroimmune Diseases 04/11/2025
An Interview With Lisa Shea, Director of Global Patient Advocacy and Engagement for Immunology at Johnson & Johnson 29/10/2025
© 2003-2026 ZARZA | AHEAD OF OUR TIME
privacy policy
In God we trust In God we trust
PreSales Questions? Click Here
or call our toll-free line at +1-888-5002068 Miami, Florida, USA